Our plenary speakers are:
Professor Michael Murphy of Cambridge University, UK. Mike’s interests are mitochondrial ROS production, and has pioneered methods to target mitochondrial ROS detection and scavenging. Mike has been a driving force behind triphenylphosphonium targeted small molecules, the most famous of which is Mito-Q.
Click Here – Professor Michael Murphy
Professor Clare Hawkins from University of Copenhagen. Clare’s research explores inflammation as a driving force in atherosclerosis, and how associated oxidants modify the structure and function of biological molecules and arterial wall cells. Clare’s group has a particular focus on hyperchlorous acid production from myeloperoxidase. Click Here – Professor Clare Hawkins
Professor Albert van der Vliet from Vermont University, USA. , Albert’s interests lie in understanding the molecular mechanisms by which biological and environmental oxidants mediate lung cell injury, inflammation, and remodelling, in chronic lung diseases such as asthma, COPD and lung cancer. Click Here – Professor Albert van der Vliet
Professor Tobias Dick of the Deutsches Krebsforschungszentrum (German Cancer Research Centre). Tobias’ work investigates H2O2 signalling pathways in metabolic stress, adaptation and cytoprotection. This work aims understand how tumor cells take advantage of redox signaling pathways. Click Here – Professor Tobias Dick